Buzzetti E - Search Results

1

Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease.

Koukias N, Buzzetti E, Tsochatzis EA. Koukias N, et al. Among authors: buzzetti e. Minerva Endocrinol. 2017 Jun;42(2):184-194. doi: 10.23736/S0391-1977.16.02567-0. Epub 2016 Nov 23. Minerva Endocrinol. 2017. PMID: 27879962 Free article. Review.

2

Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease.

Lombardi R, Buzzetti E, Roccarina D, Tsochatzis EA. Lombardi R, et al. Among authors: buzzetti e. World J Gastroenterol. 2015 Oct 21;21(39):11044-52. doi: 10.3748/wjg.v21.i39.11044. World J Gastroenterol. 2015. PMID: 26494961 Free PMC article. Review.

3

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Buzzetti E, Pinzani M, Tsochatzis EA. Buzzetti E, et al. Metabolism. 2016 Aug;65(8):1038-48. doi: 10.1016/j.metabol.2015.12.012. Epub 2016 Jan 4. Metabolism. 2016. PMID: 26823198 Review.

4

Gender differences in liver disease and the drug-dose gender gap.

Buzzetti E, Parikh PM, Gerussi A, Tsochatzis E. Buzzetti E, et al. Pharmacol Res. 2017 Jun;120:97-108. doi: 10.1016/j.phrs.2017.03.014. Epub 2017 Mar 20. Pharmacol Res. 2017. PMID: 28336373 Review.

5

Surrogate endpoints for clinical trials in non-alcoholic steatohepatitis.

Tsochatzis EA, Buzzetti E, Pinzani M. Tsochatzis EA, et al. Among authors: buzzetti e. Lancet Gastroenterol Hepatol. 2017 Aug;2(8):549-550. doi: 10.1016/S2468-1253(17)30184-X. Lancet Gastroenterol Hepatol. 2017. PMID: 28691682 No abstract available.

6

Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease.

Buzzetti E, Petta S, Manuguerra R, Luong TV, Cabibi D, Corradini E, Craxì A, Pinzani M, Tsochatzis E, Pietrangelo A. Buzzetti E, et al. Liver Int. 2019 Jul;39(7):1325-1334. doi: 10.1111/liv.14096. Epub 2019 Mar 27. Liver Int. 2019. PMID: 30851216

7

Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease.

Buzzetti E, Hall A, Ekstedt M, Manuguerra R, Guerrero Misas M, Covelli C, Leandro G, Luong T, Kechagias S, Manesis EK, Pinzani M, Dhillon AP, Tsochatzis EA. Buzzetti E, et al. Aliment Pharmacol Ther. 2019 May;49(9):1214-1222. doi: 10.1111/apt.15219. Epub 2019 Mar 18. Aliment Pharmacol Ther. 2019. PMID: 30882933

8

Comparison of point-shear wave elastography (ElastPQ) and transient elastography (FibroScan) for liver fibrosis staging in patients with non-alcoholic fatty liver disease.

Roccarina D, Iogna Prat L, Pallini G, Guerrero Misas M, Buzzetti E, Saffioti F, Aricò FM, Mantovani A, Koutli E, Goyale A, Rosselli M, Luong TV, Pinzani M, Tsochatzis EA. Roccarina D, et al. Among authors: buzzetti e. Liver Int. 2022 Oct;42(10):2195-2203. doi: 10.1111/liv.15297. Epub 2022 Jun 15. Liver Int. 2022. PMID: 35635761

9

Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes non-alcoholic fatty liver disease-authors' reply.

Buzzetti E, Tsochatzis EA. Buzzetti E, et al. Aliment Pharmacol Ther. 2019 Aug;50(3):339. doi: 10.1111/apt.15385. Aliment Pharmacol Ther. 2019. PMID: 31313369 No abstract available.

10

Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.

Komolafe O, Buzzetti E, Linden A, Best LM, Madden AM, Roberts D, Chase TJ, Fritche D, Freeman SC, Cooper NJ, Sutton AJ, Milne EJ, Wright K, Pavlov CS, Davidson BR, Tsochatzis E, Gurusamy KS. Komolafe O, et al. Among authors: buzzetti e. Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013157. doi: 10.1002/14651858.CD013157.pub2. Cochrane Database Syst Rev. 2021. PMID: 34280304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters